Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Peregrine meets with FDA to discuss phase III Cotara trial design

Nov. 6, 2002

New ER-modulatory isoflavonoids for cancer and other conditions

Nov. 6, 2002

Progenics receives funding for development of prostate cancer immunotherapies

Nov. 6, 2002

Epimmune licenses Valentis technology for use in DNA cancer vaccine products

Nov. 6, 2002

SuperGen to begin Orathecin NDA submission by year-end 2002

Nov. 5, 2002

Servier and ConjuChem report novel albumin-binding metalloproteinase inhibitors

Nov. 5, 2002

Progen receives clearance to begin PI-166 clinical trial

Nov. 5, 2002

Pharmacia researchers describe new CDK inhibitors for cancer and other indications

Nov. 5, 2002

Influence of renal dysfunction on safety profile of pemetrexed

Nov. 5, 2002

Pharmacokinetics of epothilone B assessed in patients with advanced cancer

Nov. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...